Cyclo Therapeutics (CYTH)
NASDAQ:CYTH
US Market
Holding CYTH?
Track your performance easily

Cyclo Therapeutics (CYTH) Financial Statements

191 Followers

Cyclo Therapeutics Financial Overview

Cyclo Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.882; its P/E ratio is -0.78; Cyclo Therapeutics is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 123.10K$ 202.45K$ 311.40K$ 495.50K$ 117.12K
Gross Profit$ 109.72K$ 202.45K$ 295.90K$ 536.39K$ 144.49K
EBIT$ -5.25M$ -4.34M$ -5.64M$ -4.77M$ -4.64M
EBITDA$ -5.25M$ -4.34M$ -5.64M$ -4.77M-
Net Income Common Stockholders$ -5.25M$ -4.33M$ -5.64M$ -4.77M$ -4.64M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.12M$ 3.00M$ 9.25M$ 1.80M$ 841.53K
Total Assets$ 4.72M$ 7.16M$ 13.25M$ 5.60M$ 4.64M
Total Debt$ 3.00M$ 665.06K$ 1.03M$ 45.23K$ 49.41K
Net Debt$ 1.88M$ -2.33M$ -8.21M$ -1.76M$ -792.13K
Total Liabilities$ 9.84M$ 6.55M$ 8.49M$ 6.65M$ 6.13M
Stockholders Equity$ -5.12M$ 609.76K$ 4.76M$ -1.05M$ -1.48M
Cash Flow-
Free Cash Flow$ -3.85M$ -6.18M$ -4.30M$ -4.04M-
Operating Cash Flow$ -3.85M$ -6.18M$ -4.30M$ -4.04M-
Investing Cash Flow--$ -2.42K--
Financing Cash Flow$ 1.97M$ -69.28K$ 11.74M$ 5.00M-
Currency in USD

Cyclo Therapeutics Earnings and Revenue History

Cyclo Therapeutics Debt to Assets

Cyclo Therapeutics Cash Flow

Cyclo Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis